Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matteo Ferro

Showing results (171-180 of 420) with videos related to

Pageof 42
Sort By:
The Prostate|July 24, 2012
Prostate health index (phi) and prostate cancer antigen 3 (PCA3) significantly improve diagnostic accuracy in patients undergoing prostate biopsySisto Perdonà, Dario Bruzzese, Matteo Ferro, et al.
Frontiers in Endocrinology|July 1, 2021
Does Exist a Differential Impact of Degarelix <i>Versus</i> LHRH Agonists on Cardiovascular Safety? Evidences From Randomized and Real-World StudiesAlessandro Sciarra, Gian Maria Busetto, Stefano Salciccia, et al.
Urologic Oncology|March 21, 2015
Body mass index was associated with upstaging and upgrading in patients with low-risk prostate cancer who met the inclusion criteria for active surveillanceOttavio de Cobelli, Daniela Terracciano, Elena Tagliabue, et al.
European Urology Focus|July 30, 2017
Statin Use and Survival in Patients with Metastatic Castration-resistant Prostate Cancer Treated with Abiraterone AcetateGiuseppe Di Lorenzo, Guru Sonpavde, Gregory Pond, et al.
World Journal of Urology|February 5, 2026
Time to BCR and cancer-specific mortality after radiotherapy or prostatectomy: implications for risk stratification and follow-upFrancesco Pellegrino, Ralph Grauer, Ugo Giovanni Falagario, et al.
Urologia Internationalis|April 13, 2021
Mechanical and Ablative Minimally Invasive Techniques for Male LUTS due to Benign Prostatic Obstruction: A Systematic Review according to BPH-6 EvaluationFrancesco Cantiello, Deborah Fimognari, Marina Di Mauro, et al.
BJU International|September 11, 2012
Cisplatin and 5-fluorouracil in inoperable, stage IV squamous cell carcinoma of the penisGiuseppe Di Lorenzo, Carlo Buonerba, Piera Federico, et al.
Cancers|May 13, 2020
Long-Term Follow-Up Outcomes after Percutaneous US/CT-Guided Radiofrequency Ablation for cT1a-b Renal Masses: Experience from Single High-Volume Referral CenterGiovanni Mauri, Francesco Alessandro Mistretta, Guido Bonomo, et al.
Cancers|May 28, 2022
Immune Checkpoint Inhibitors as a Neoadjuvant/Adjuvant Treatment of Muscle-Invasive Bladder Cancer: A Systematic ReviewBiagio Barone, Armando Calogero, Luca Scafuri, et al.
Translational Andrology and Urology|January 18, 2021
Systematic sampling during MRI-US fusion prostate biopsy can overcome errors of targeting-prospective single center experience after 300 cases in first biopsy settingEmanuel Cata, Iulia Andras, Matteo Ferro, et al.
Pageof 42

Showing results (171-180 of 420) with videos related to

Sort By:
Pageof 42
The Prostate|July 24, 2012
Prostate health index (phi) and prostate cancer antigen 3 (PCA3) significantly improve diagnostic accuracy in patients undergoing prostate biopsySisto Perdonà, Dario Bruzzese, Matteo Ferro, et al.
Frontiers in Endocrinology|July 1, 2021
Does Exist a Differential Impact of Degarelix <i>Versus</i> LHRH Agonists on Cardiovascular Safety? Evidences From Randomized and Real-World StudiesAlessandro Sciarra, Gian Maria Busetto, Stefano Salciccia, et al.
Urologic Oncology|March 21, 2015
Body mass index was associated with upstaging and upgrading in patients with low-risk prostate cancer who met the inclusion criteria for active surveillanceOttavio de Cobelli, Daniela Terracciano, Elena Tagliabue, et al.
European Urology Focus|July 30, 2017
Statin Use and Survival in Patients with Metastatic Castration-resistant Prostate Cancer Treated with Abiraterone AcetateGiuseppe Di Lorenzo, Guru Sonpavde, Gregory Pond, et al.
World Journal of Urology|February 5, 2026
Time to BCR and cancer-specific mortality after radiotherapy or prostatectomy: implications for risk stratification and follow-upFrancesco Pellegrino, Ralph Grauer, Ugo Giovanni Falagario, et al.
Urologia Internationalis|April 13, 2021
Mechanical and Ablative Minimally Invasive Techniques for Male LUTS due to Benign Prostatic Obstruction: A Systematic Review according to BPH-6 EvaluationFrancesco Cantiello, Deborah Fimognari, Marina Di Mauro, et al.
BJU International|September 11, 2012
Cisplatin and 5-fluorouracil in inoperable, stage IV squamous cell carcinoma of the penisGiuseppe Di Lorenzo, Carlo Buonerba, Piera Federico, et al.
Cancers|May 13, 2020
Long-Term Follow-Up Outcomes after Percutaneous US/CT-Guided Radiofrequency Ablation for cT1a-b Renal Masses: Experience from Single High-Volume Referral CenterGiovanni Mauri, Francesco Alessandro Mistretta, Guido Bonomo, et al.
Cancers|May 28, 2022
Immune Checkpoint Inhibitors as a Neoadjuvant/Adjuvant Treatment of Muscle-Invasive Bladder Cancer: A Systematic ReviewBiagio Barone, Armando Calogero, Luca Scafuri, et al.
Translational Andrology and Urology|January 18, 2021
Systematic sampling during MRI-US fusion prostate biopsy can overcome errors of targeting-prospective single center experience after 300 cases in first biopsy settingEmanuel Cata, Iulia Andras, Matteo Ferro, et al.
Pageof 42